Endocrine Abstracts

Introduction: T-Coach program is a phone support platform for patients with type 2 diabetes (T2D) treated with insulin glargine 300 U/ml in order to adjust basal insulin dose, reinforce diabetes education and encourage patients to get their goals through regular phone calls. The aim of the study was to evaluate T-Coach program effectiveness in metabolic control and level of satisfaction in patients with T2D.

Methods: We conducted a retrospective, descriptive and observational study that includes patients with T2D enrolled in T-Coach program from October 2016 to October 2019, attending the Endocrinology Unit of Puerta del Mar University Hospital (Cádiz). We analyzed demographic and clinical characteristics, biochemical parameters (fasting glycemia, HbA1c), insulin dose and number of concomitant drugs before, at 3 months and at 6 months after program inclusion. Patient’s satisfaction with use of the platform was evaluated.

Results: 105 patients were included in T-Coach program. The mean age was 66.96 ± 11.27 years old, with a mean time of evolution of T2D about 13.99 ± 8.17 years. We verified that 56.9% of patients (n = 61) had microangiopathic complications and 18.6% (n = 22) had macrovascular complications. Basal insulin dose was 31.01 ± 18.02 U/day and 35.06 ± 20.75 U/day at 6 months. Mean fasting blood glucose levels dropped from 205.19 ± 75.24 mg/dl to 117.1 ± 53.50 mg/dl at 6 months (P < 0.001). Mean baseline HbA1c was 9.27 ± 1.75% and at 6 months 7.26 ± 1.39% (P < 0.001). The degree of patient satisfaction was high, with scores above 9/10 on most items evaluated.

Conclusions: In our region, T-Coach program is an effective way to help patients with T2D to reach their optimal insulin glargine U300 dose and improves glycemic control. Majority of patients expressed high satisfaction with the support programme.